A Study of IBI3031 in Participants With Thyroid Eye Disease

Abroad (travel likely)RecruitingPHASE1

Conditions

Thyroid Eye Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

the First Hospital of China Medical University, Shenyang, Liaoning, China
Contact: Study coordinator (Zhongyan Dan) · shanzhongyan@hotmail.com · 02483282152

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MHB018A Treatment in Patients With Chronic Thyroid Eye Disease

Thyroid Eye Disease (TED)

Abroad (travel likely)RecruitingPHASE3

Shanghai, China

An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease

Thyroid Eye Disease

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · Kissimmee, United States

Tofacitinib for Glucocorticoid-Resistant Moderate-to-Severe Thyroid Eye Disease

Thyroid Eye Disease, TED · Graves Ophthalmopathy · Graves Orbitopathy

Abroad (travel likely)RecruitingPHASE2

Xiamen, China

Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease

Thyroid Eye Disease, TED · Graves Ophthalmopathy

Abroad (travel likely)Recruiting

Taipei, Taiwan